Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03967522
Title Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases (CABRAMET)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications

renal cell carcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest-Site Paul Papin Not yet recruiting Angers 49005 France Details
CHU Besancon Recruiting Besançon 25030 France Details
Centre Georges François Leclerc Not yet recruiting Dijon 21079 France Details
Centre Leon Berard Recruiting Lyon 69373 France Details
Centre Val d'Aurelle Not yet recruiting Montpellier 34928 France Details
Institut de Cancérologie de la Lorraine Recruiting Nancy 54519 France Details
Institut de Cancérologie de l'Ouest-site René Gauducheau Recruiting Saint-Herblain 44805 France Details
IUCT-Institut Claudius Regaud Recruiting Toulouse 31059 France Details
Institut Gustave Roussy Not yet recruiting Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field